Bimatoprost powder — Class II drug recall D-0386-2025
Terminated recall by Medisca Inc., reported 2025-04-30, distributed nationwide. CGMP Deviations
| Recall number | D-0386-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medisca Inc., Irving, TX, United States |
| Recall initiated | 2025-03-31 |
| Classified | 2025-04-21 |
| Reported by FDA | 2025-04-30 |
| Terminated | 2025-10-10 |
| Distributed | Nationwide (US) |
| Quantity | 161.6 grams |
| Reason classes | cgmp |
| NDC | 38779-3066-03, 38779-3066-06, 38779-3066-09 |
| Lot numbers | 201727/A/B/C/D/E, 208475/A/B/D/E/G/H |
| Expiration dates | 2027-05-31, 2028-09-30 |
Product
Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0386-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.